Riskpilot← Back to searchSign inGet full accessBjertorp Hästklinik AB
ABActiveOrg 5569365173Kvänum Skulltorp 5Veterinary activities · NACE 7500Est. 20131 employees
Revenue 2024
SEK 4M
+12% vs 2023
EBITDA margin
5.0%
+471% vs 2023
Equity ratio
19.3%
Financial strength
Net profit 2024
SEK 61K
1 employees
| Revenue | SEK 4M | +12% |
| EBITDA | SEK 200K | +471% |
| Net profit | SEK 61K | — |
| Total assets | SEK 9,3M | +11% |
| Equity | SEK 1,8M | +4% |
| Employees | 1 | — |
Legal name
Bjertorp Hästklinik AB
Org number
5569365173
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
2 juli 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna
Company purpose
Föremålet för bolagets verksamhet är att bedriva hästveterinärverksamhet och erbjuda veterinära tjänster och därmed förenlig verksamhet.
Address
Kvänum Skulltorp 5
Phone
+46511343030
Email
anna-karin.sandberg@husabyhastklinik.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 917 | 4 664 | 3 697 | 3 564 | 3 975 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 219 | 377 | 6 | 35 | 200 |
| Depreciation & amort. | −109 | −111 | −160 | −138 | −107 |
| EBIT | 110 | 266 | −154 | −103 | 93 |
| Net financials | −2 | — | 5 | 72 | 27 |
| Profit before tax | 99 | 228 | 65 | 2 | 80 |
| Tax | −22 | −49 | −6 | −2 | −19 |
| Net profit | 77 | 179 | 59 | 0 | 61 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 555 | 7 073 | 7 455 | 8 376 | 9 293 |
| Equity | 1 494 | 1 672 | 1 731 | 1 732 | 1 793 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 386 | 4 687 | 5 224 | 6 178 | 6 993 |
| Total debt | 3 386 | 4 687 | 5 224 | 6 178 | 6 993 |
EBITDA margin
5.0%
This company
15.8%
Market median
-68% vs market
20202024
Equity ratio
19.3%
This company
38.2%
Market median
-49% vs market
20202024
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
20202024
Net profit margin
1.5%
This company
8.1%
Market median
-81% vs market
20202024
Asset turnover
0.43×
This company
1.12×
Market median
-62% vs market
20202024
Debt / equity
4.18×
This company
0.62×
Market median
-574% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Audit | 2020 | |
| Former (1) | ||
BA Auditor Substitute | Auditor Substitute | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Husaby Hästklinik AB
Bjertorp Hästklinik AB Board members of Bjertorp Hästklinik AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ingemar Torsten Kenneth Venemyr | Audit | 0 companies |
| Britt-Marie Agneta Lenz | Auditor Substitute | 0 companies |
| Anna-Karin Sandberg | Chairman | 0 companies |
| Torunn Mehammer | Board of Directors | 0 companies |
| Jan Henrik Nyberg | Board of Directors | 0 companies |